181308-57-6

Basic information

• Product Name: TERT-BUTYL TRANS-4-FORMYLCYCLOHEXYLCARBAMATE
• Synonyms: TERT-BUTYL TRANS-4-FORMYLCYCLOHEXYLCARBAMATE;trans-Boc-4-aMinocyclohexanecarbaldehyde;tert-butyl (1r,4r)-4-forMylcyclohexylcarbaMate;trans-4-(Boc-aMino)cyclohexanecarboxaldehyde, 97%;trans-(4-Formyl-cyclohexyl)-carbamic acid tert-butyl ester;trans-tert-Butyl (4-formylcyclohexyl)carbamate;Carbamic acid, N-(trans-4-formylcyclohexyl)-,1,1-dimethylethyl ester;tert-Butyl (trans-4-formylcyclohexyl)
• CAS NO: 181308-57-6
• Molecular Formula: C₁₂H₂₁NO₃
• Molecular Weight: 227.3
• Mol File: 181308-57-6.mol
• Article Data: 13

Chemical Properties

• Boiling Point: 339.5±31.0 °C(Predicted)
• Appearance: /
• Density: 1.04±0.1 g/cm3(Predicted)
• PKA: 12.33±0.40(Predicted)
• Water Solubility: Slightly soluble in water.
• CAS DataBase Reference: TERT-BUTYL TRANS-4-FORMYLCYCLOHEXYLCARBAMATE(CAS DataBase Reference)
• NIST Chemistry Reference: TERT-BUTYL TRANS-4-FORMYLCYCLOHEXYLCARBAMATE(181308-57-6)
• EPA Substance Registry System: TERT-BUTYL TRANS-4-FORMYLCYCLOHEXYLCARBAMATE(181308-57-6)

Safety Data

• Hazardous Substances Data: 181308-57-6(Hazardous Substances Data)

Usage

Chemical Properties

White to light yellow solid

Uses

trans-4-(Boc-amino)cyclohexanecarboxaldehyde is used as a intermediate in pharmaceutical.

Upstream product

• 146307-51-9 methyl (1R,4R)-4-((tert-butoxycarbonyl)amino)cyclohexane-1-carboxylate 
• 128699-69-4 C₉H₁₅NO₄ 
• 24424-99-5 di-tert-butyl dicarbonate 
• 1776-53-0 trans-4-aminocyclohexanecarboxylic acid 
• 53292-90-3 trans-4-(tert-butoxycarbonylamino)cyclohexanoic acid 
• 1678-68-8 ethyl trans-4-aminocyclohexanecarboxylate 
• 27960-59-4 trans-4-aminocyclohexanecarboxylic acid hydrochloric acid 
• 239074-29-4 trans (4-hydroxymethyl-cyclohexyl)-carbamic acid tert-butyl ester 

Downstream Products

• 1315498-84-0 3-(trans-4-aminocyclohexyl)propanenitrile trifluoroacetic acid salt 
• 1315499-04-7 trans-[4-(2-methanesulfonyl-ethyl)-cyclohexyl]-carbamic acid tert-butyl ester 
• 1315499-05-8 trans-4-(2-methanesulfonyl-ethyl)-cyclohexylamine 
• 1313365-58-0 {4-[(4-iodo-phenylamino)-methyl]-trans-cyclohexyl}-carbamic acid tert-butyl ester 
• 1313365-98-8 [[2-(tert-butoxycarbonyl-methyl-amino)-ethyl]-(4-{[(4-iodo-phenyl)-methyl-amino]-methyl}-trans-cyclohexyl)-amino]-acetic acid methyl ester 
• 1313365-97-7 4-(4-{[(4-iodo-phenyl)-methyl-amino]-methyl}-trans-cyclohexyl)-1-methyl-piperazin-2-one 
• 1313363-54-0 (S)-1-(4-chloro-phenyl)-7-isopropoxy-6-methoxy-2-(4-{methyl-[4-(4-methyl-3-oxo-piperazin-1-yl)-trans-cyclohexylmethyl]-amino}-phenyl)-1,4-dihydro-2H-isoquinolin-3-one 
• 1313365-95-5 (trans-4-amino-cyclohexylmethyl)-(4-iodo-phenyl)-methyl-amine 
• 947141-86-8 tert-butyl ((1r,4r)-4-ethynylcyclohexyl)carbamate 

Relevant articles and documents

CEREBLON BINDING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH

Provided herein are piperidine dione compounds having the following structure: wherein R1, R2, R3, R4, L, V, X, A, A′, a and m are as defined herein, compositions comprising an effective amount of a piperidine dione compound, and methods for treating or preventing an androgen receptor mediated disease.

CEREBLON BINDING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH

Provided herein are piperidine dione compounds having the following structure: wherein RN, R1, R2, R3, R4, RN, L, V, X, a, m, and n are as defined herein, compositions comprising an effective amount of a piperidine dione compound, and methods for treating or preventing an androgen receptor mediated disease.

FUSED PYRIDINES WHICH ACT AS INHIBITORS OF H-PGDS

A compound of formula (I) wherein R1, R2, R3, R4 χ γ anc| A are as defined herein. The compounds of the present invention are inhibitors of hematopoietic prostaglandin D synthase (H-PGDS) and can be useful in th